We’re pleased to announced that $NTLA received authorization of its Clinical Trial Application by @MHRAgovuk to initiate a global Phase 1 clinical trial of NTLA-2001 for the treatment of #ATTR. Full press release here: https://t.co/A1Cl9gBPLB #genomeediting https://t.co/7w6b7zKJgs